Dexcom Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 1.0B 986.1M 882.9M 949.0M
Cost of revenue 407.3M 399.1M 381.0M 390.1M
Gross profit 623.3M 587.0M 502.0M 558.9M
Operating expense
Research & development 134.2M 126.3M 123.7M 118.9M
Selling general and admin 282.4M 279.5M 264.3M 279.0M
Other operating expenses
Operating income 206.7M 181.2M 113.9M 161.0M
Non operating interest income
Income 27.9M 23.9M 24.3M 25.3M
Expense 4.0M 4.0M 4.0M 4.2M
Other income expense 69.7M 4.4M -2.7M -2.0M
Pretax income 300.2M 205.5M 131.5M 180.1M
Tax provision 58.4M 52.2M 41.7M 50.8M
Net income 241.9M 153.2M 89.8M 129.3M
Basic EPS 0.5 0.3 0.4
Diluted EPS 0.5 0.3 0.4
Basic average shares 334.2M 333.3M 332.9M
Diluted average shares 347.9M 347.3M 346.6M
EBITDA 358.5M 263.2M 186.6M 233.5M
Net income from continuing op. 241.9M 153.2M 89.8M 129.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 47 minutes

08:07
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).